Two years into broad employer adoption, the GLP-1 question has moved from whether to cover these medications to whether the results last. Discontinuation is common, weight often returns, and the spend stays in the plan. That is true whether or not an employer covers them, because employees are accessing them anyway. This session gives HR and benefits leaders a practical framework: what actually drives discontinuation and what prevents it, how to support employees using GLP-1s and those who never will under one program, and which signals at 6 and 12 months show whether early results are becoming lasting workforce outcomes.
Meet the Presenters
SHRM certification has approved this webinar for 1 PDC toward SHRM-CP or SHRM-SCP recertification. A program code will be provided at the end of the webinar.